Income StatementBalance SheetCash FlowSegments
Johnson & Johnson logo

Johnson & Johnson Cash Flow Statement

Operating, investing, and financing cash movements

Johnson & Johnson generated $22.9B in operating cash flow over the trailing twelve months. After $5.1B in capital expenditures, free cash flow was $17.8B. Free cash flow decreased 0.1% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$22.9BNet Cash From Investing (TTM)-$24.3BNet Cash From Financing (TTM)-$15.4BCapital Expenditures (TTM)$5.1BDepreciation And Amortization Cf (TTM)$7.7BNet Change In Cash (TTM)-$1.7B
Latest FilingQ1 2026
Report Date2026-04-22
Market Cap$564.11B
P/E Ratio26.81
ROE26.42%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$1.0M$0.0$14.5B$1.0M$3.0B—
Proceeds from Sales of Assets and Subsidiaries$52.0M$279.0M$53.0M$76.0M$312.0M$29.0M
Capital expenditures$1.6B$795.0M$1.0B$1.2B$1.8B$1.0B
Payment for (Proceeds from) Other Investing Activity$72.0M$30.0M$36.0M$33.0M$63.0M$54.0M
Payments To Acquire In Process Research And Development Assets—$14.0M$355.0M$16.0M—$0.0
Payments To Acquired In-Process Research And Development Assets$445.8M$96.3M$96.3M$96.3M$96.3M—
Proceeds from disposition of marketable securities and other investments$290.0M$218.0M$735.0M$489.0M$219.0M$209.0M
Proceeds from disposition of property, plant and equipment/other$52.0M$279.0M$53.0M$76.0M$312.0M$29.0M
Credit support agreements activity, net$818.0M$296.0M-$3.0B——-$31.0M
Net cash from investing activities-$1.3B-$297.0M-$18.3B-$542.0M-$4.5B-$1.0B
Purchases of investments$262.0M$251.0M$180.0M$246.0M$243.0M$144.0M
Proceeds from sale of PPE and intangibles$52.0M$279.0M$53.0M$76.0M$312.0M$29.0M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable—-$2.1B$1.2B$2.0B$1.3B-$3.9B
Change in accounts receivable—$926.0M$1.4B——$595.0M
Change in inventories$90.0M$146.0M$510.0M$748.0M$46.0M$431.0M
Change in other liabilities$359.0M-$6.5B—-$270.0M—-$629.0M
Benefit from Receivables$22.0M-$4.0M$7.0M-$9.0M—-$8.0M
Deferred income taxes-$16.0M$2.2B$825.0M$2.2B—$159.0M
Depreciation and amortization$1.9B$1.8B$1.9B$1.8B$2.0B$2.0B
Net cash from operating activities$7.0B$4.2B$3.9B$9.2B$7.3B$2.5B
Net income$3.4B$11.0B$5.5B$5.2B$5.1B$5.2B
Asset write-downs$26.0M$30.0M$0.0$93.0M$81.0M$36.0M
Gain (Loss) on Sale of Assets and Asset Impairment Charges$1.0M$75.0M$0.0$57.0M$132.0M-$12.0M
Charges for acquired in-process research and development assets—$16.0M$76.0M$17.0M—$2.0M
Increase (Decrease) in Other Operating Assets-$768.0M$1.3B$4.9B$1.5B—-$349.0M
Accounts Receivable, Credit Loss Expense (Reversal)$22.0M-$4.0M$7.0M-$9.0M—-$8.0M
Charges for acquired in-process research and development$460.3M$27.3M$27.3M$27.3M$27.3M—
Stock-based compensation$238.0M$288.0M$410.0M$347.0M$309.0M$300.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from issuance of debt$0.0$9.1B———$0.0
Payments of Ordinary Dividends$3.0B$3.0B$3.1B$3.1B$3.1B$3.1B
Proceeds From The Exercise Of Stock Options And Excess Tax Benefits$124.0M$450.0M$107.0M$1.3B$1.6B$1.2B
Other, net—$40.0M$1.0M-$49.0M-$26.0M-$588.0M
Proceeds from issuance of commercial paper and other short-term borrowings$3.3B$8.8B$565.0M$1.3B$3.9B$12.4B
Credit support agreements activity, net$267.0M-$3.0M-$268.0M——-$109.0M
Repayments of Senior Debt—$751.0M$3.0M$1.0B—$2.0B
Repayments of Short-Term Debt$1.1B$2.1B$2.9B$5.5B$1.8B$3.2B
Proceeds from Issuance of Commercial Paper and Short-Term Borrowings$3.3B$8.8B$565.0M$1.3B$3.9B$12.4B
Payment of Deferred Purchase Consideration—$40.0M$1.0M-$49.0M-$26.0M-$588.0M
Noncontrolling interest transactions and other—$40.0M$1.0M-$49.0M-$26.0M-$588.0M
Net cash from financing activities-$1.3B$10.4B-$5.7B-$8.9B-$1.4B$530.0M
Noncontrolling Interests Activity and Other—$40.0M$1.0M-$49.0M-$26.0M-$588.0M
Proceeds from Commercial Paper and Secured Lines of Credit$3.3B$8.8B$565.0M$1.3B$3.9B$12.4B
Repurchases of common stock$282.0M$2.1B$0.0$1.9B$1.9B$4.0B

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$5.4B$3.4B$2.8B$8.0B$5.5B$1.5B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$198.0M$70.0M$154.0M—$23.0M-$25.0M
Net increase (decrease) in cash$4.1B$14.4B-$19.9B-$346.0M—$2.0B
Interest Paid$497.5M$494.3M$494.3M$494.3M$494.3M—
Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards$387.8M$647.8M$647.8M$647.8M$647.8M—

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$1.7B$1.6B$1.6B$1.6B$1.6B—
Interest paid$477.8M$465.8M$465.8M$465.8M$465.8M—